 |
| Confused? |
As the new 'Medical Marijuana' industry emerges, there is so much conflicting information about this plant's safety and efficacy, not to mention the controversy preceding it and still surrounding it, it becomes absolutely astounding, let alone confusing to decipher the array of contradicting information. How do we reconcile all this information out there? Who can we trust for the truth? Why does the government classify information?
In 1961, the United Nations introduced the Single Convention on Drug Control, an international treaty requiring signatory members to adopt and implement similar legislation including, against the cannabis plant, This entailed treating all forms of cannabis as a dangerous drug. The UN continues to state that cannabis has no recognized or known medical use and it carries a high potential risk for abuse. Consequently, to conform to society and per 'Blue Ribbon' reports, most, if not all countries conformed to eradicating the cannabis plant, including its industrial hemp cousin.
Would it come as a shock to learn that prior to the adoption of the International Treaty - Single Convention on Drugs, and up until now, both the US government, through their Ole Miss medical marijuana lab, and the British government, through their GW Pharma research lab, have continuously filed patents on the various health benefits they discovered in the cannabis plant?
To understand the emerging medical marijuana market today, and why only two out of hundreds of cannabinoids are being sold in the new market, requires an understanding of how those two cannabinoids came to dominate.
After the UN created the Single Convention on Narcotic Drugs, the UNODC emerged. The UNODC is an acronym for the United Nations Office on Drug Control. The UNODC, since the Single Convention treaty, has issued their publication: Recommended methods for the identification and analysis of cannabis and cannabis products
The above link will take you to a new tab and is the 2009 edition of the UNODC's latest publication on the subject. Since the creation of the Single Convention, drug analysis labs have been taught to use the ratio of THC to CBD as a reliable method for determining drug-type weed from fiber-type weed. Just as archaic then, the method for separating the compounds in a sample of pot was and still is gas chromatography.
The problem behind the use of gas chromatography as a method of separating compounds in a sample of cannabis, was in the separation of cannabidiol, CBD, from cannabichromene, CBC - it wasn't able to!
The emerging 'marijuana' market today, is still only focused on disclosing the quantity of THC to CBD, as if those are the only two cannabinoids in the plant.
The following link is to a kindle book that can provide you with additional information:
